Impact of Diabetes Mellitus on the Treatment Effect of Percutaneous or Surgical Revascularization for Patients With Unprotected Left Main Coronary Artery Disease. A Subgroup Analysis of the MAIN-COMPARE Study

JACC: Cardiovascular Interventions

Volumn 2, Issue 10, 2009, Pages 956-963

  Kim, Won Jang ^a   Park, Duk Woo ^a   Yun, Sung Cheol ^a   Lee, Jong Young ^a   Lee, Seung Whan ^a   Kim, Young Hak ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

coronary artery bypass graft; diabetes mellitus; left main coronary artery disease; stent

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350094683     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.07.010     Document Type: Article

References (31)

1. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (1979) 2035-2038
2. Kip K.E., Faxon D.P., Detre K.M., Yeh W., Kelsey S.F., and Currier J.W. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty registry. Circulation 94 (1996) 1818-1825
3. Rodriguez A.E., Baldi J., Fernández Pereira C., et al. Five-year follow-up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II). J Am Coll Cardiol 46 (2005) 582-588
4. Serruys P.W., Ong A.T.L., van Herwerden L.A., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
5. Hong S.J., Kim M.H., Ahn T.H., et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart 92 (2006) 1119-1124
6. Kumar R., Lee T.T., Jeremias A., et al. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol 100 (2007) 1187-1191
7. Stein B., Weintraub W.S., Gebhart S.S.P., et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91 (1995) 979-989
8. Thourani V.H., Weintraub W.S., Stein B., et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 67 (1999) 1045-1052
9. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
10. Seung K.B., Park D.W., Kim Y.H., et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358 (2008) 1781-1792
11. Park S.J., Kim Y.H., Lee B.K., et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
12. Park D.W., Park S.W., Park K.H., et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
13. Eagle K.A., Guyton R.A., Davidoff R., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery; American Society for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44 (2004) e213-e310
14. Chieffo A., Morici N., Maisano F., et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
15. Xie J., and Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 24 (2005) 3089-3110
16. Robins J.M. Marginal structural models. 1997 Proceedings of the American Statistical Association, Section on Bayesian Statistical Science (1998), American Statistical Association, Alexandria, VA 1-10
17. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., and Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 418-423
18. Sabik III J.F., Blackstone E.H., Gillinov A.M., Smedira N.G., and Lytle B.W. Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation 114 (2006) I-454-I-460
19. Slaughter M.S., Olson M.M., Lee J.T.J., and Ward H.B. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg 56 (1993) 1063-1068
20. Abizaid A., Costa M.A., Centemero M., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 533-538
21. Roiron C., Sanchez P., Bouzamondo A., Lechat P., and Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92 (2006) 641-649
22. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 337 (2008) a1331
23. Stettler C., Allemann S., Egger M., Windecker S., Meier B., and Diem P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 92 (2006) 650-657
24. Iijima R., Ndrepepa G., Mehilli J., et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 154 (2007) 688-693
25. Serruys P.W., Ong A.T.L., Morice M.C., et al. Arterial revascularization therapies study part II-sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 1 (2005) 147-156
26. The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360 (2009) 2503-2515
27. Farkouh M.E., Dangas G., Leon M.B., et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial. Am Heart J 155 (2008) 215-223
28. Kapur A., Malik I.S., Bagger J.P., et al. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J 149 (2005) 13-19
29. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
30. Park D.W., Flaherty J.D., Davidson C.J., et al. Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in Asian patients. Am J Cardiol 103 (2009) 646-652
31. Park D.W., Yun S.C., Lee S.W., et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117 (2008) 2079-2086